Oral Insulin

This study is currently active

This study is to evaluate the efficacy and safety of oral insulin in patients with Type 2 Diabetes Mellitus. With the study, we can focus on how there are no injections needed which could help individuals with needle phobias.

Eligibility Criteria

  • Male and female subjects aged 18 and older.
  • Established diagnosis of Type 2 Diabetes for at least 6 months , with A1C ≥ 7.5%.
  • Stable dose of metformin (at least 1500 mg or maximal tolerated dose) for a period of at least 3 months.
  • Taking metformin only or metformin in addition to no more than two of the following: DPP-4, SGLT-2, or TZD.
  • Body mass index (BMI) of up to 40, with no more than 5 kg gain or loss in the 3 months prior to Screening.
  • Renal function – eGFR > 30 ml/min/1.73 m2
  • Females of childbearing potential must have a negative serum pregnancy test result at Screening.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03467932

Participate in a Study

Submit the form and a clinical study expert will get in touch with you.

Want to know more about our clinical trials?